Integrative analysis reveals novel pathways mediating the interaction between adipose tissue and pancreatic islets in obesity in rats

Diabetologia

Volumn 57, Issue 6, 2014, Pages 1219-1231

  Malpique, Rita ^a,b   Figueiredo, Hugo ^a,b   Esteban, Yaiza ^a,b   Rebuffat, Sandra A ^a,b   Hanzu, Felicia A ^a,c   Vinaixa, Maria ^b,d   Yanes, Oscar ^b,d   Correig, Xavier ^b,d   Barceló Batllori, Sílvia ^e   Gasa, Rosa ^a,b   Kalko, Susana G ^f   Gomis, Ramon ^a,b,c,f  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^e BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Data integration; Metabolomics; Obesity; Pancreatic islets; Peripancreatic adipose tissue; Proteomics; Secretome; Transcriptomics

Indexed keywords

CHOLESTEROL; FATTY ACID BINDING PROTEIN 4; LIVER X RECEPTOR; RETINOID X RECEPTOR; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; GENE EXPRESSION; IMMUNE RESPONSE; INFLAMMATION; LIPID DEGRADATION; MALE; METABOLITE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT; WISTAR RAT; ANIMAL; METABOLISM; PANCREAS ISLET; PROTEOMICS;

ADIPOSE TISSUE; ANIMALS; ISLETS OF LANGERHANS; MALE; OBESITY; PROTEOMICS; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 84901240949     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3205-0     Document Type: Article

References (42)

1. Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840-846
2. Yudkin JS, Eringa E, Stehouwer CD (2005) "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365:1817-1820
3. Bostrom P, Wu J, Jedrychowski MP et al (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463-468
4. Palau N, Rebuffat SA, Altirriba J et al (2012) Role of IGFBP-3 in the regulation of beta-cell mass during obesity: adipose tissue/beta-cell cross talk. Endocrinology 153:177-187
5. Rebuffat SA, Olivera JM, Altirriba J et al (2013) Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat. Diabetologia 56:2446-2455
6. Claret M, Corominola H, Canals I et al (2005) Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology 146:4362-4369
7. Fernandez-Alvarez J, Barbera A, Nadal B et al (2004) Stable and functional regeneration of pancreatic beta cell population in nSTZ-rats treated with tungstate. Diabetologia 47:470-477
8. Irizarry RA, Hobbs B, Collin F et al (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264
9. Breitling R, Armengaud P, Amtmann A, Herzyk P (2004) Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573:83-92
10. Barcelo-Batllori S, Kalko SG, Esteban Y, Moreno S, Carmona MC, Gomis R (2008) Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue. Mol Cell Proteomics 7:378-393
11. Marouga R, David S, Hawkins E (2005) The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382:669-678
12. Karp NA, Kreil DP, Lilley KS (2004) Determining a significant change in protein expression with DeCyder during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics 4:1421-1432
13. Bendtsen JD, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340:783-795
14. Papazoglu M, Fiehn O (2009) Metabolite identification in blood plasma using GC/MS and the Agilent Fiehn GC-MS Metabolomics RTL Library. Agilent Application Note. Available from http://www.chem.agilent.com/Library/ applications/5990-3638en-lo%20CMS.pdf. Accessed November 2012
15. Hanzu FA, Vinaixa M, Papageorgiou A et al (2013) Obesity rather than regional fat depots marks the metabolomic pattern of adipose tissue: an untargeted metabolomic approach. Obesity (Silver Spring). doi: 10.1002/oby.20541
16. Brugnara L, Vinaixa M, Murillo S, et al. Metabolomics approach for analyzing the effects of exercise in subjects with type 1 diabetes mellitus. PLoS ONE 7:e40600
17. Sampey BP, Vanhoose AM, Winfield HM et al (2011) Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring) 19:1109-1117
18. Joseph SB, Tontonoz P (2003) LXRs: new therapeutic targets in atherosclerosis? Curr Opin Pharmacol 3:192-197
19. Alkhouri N, Gornicka A, Berk MP et al (2010) Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem 285:3428-3438
20. Roncari DA, Lau DC, Kindler S (1981) Exaggerated replication in culture of adipocyte precursors from massively obese persons. Metabolism 30:425-427
21. Lopez IP, Marti A, Milagro FI et al (2003) DNA microarray analysis of genes differentially expressed in diet-induced (cafeteria) obese rats. Obes Res 11:188-194
22. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM (2001) Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem 276:34167-34174
23. Keophiphath M, Rouault C, Divoux A, Clement K, Lacasa D (2010) CCL5 promotes macrophage recruitment and survival in human adipose tissue. Arterioscler Thromb Vasc Biol 30:39-45
24. Kitade H, Sawamoto K, Nagashimada M et al (2012) CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes 61:1680-1690
25. Kwon EY, Shin SK, Cho YY et al (2012) Time-course microarrays reveal early activation of the immune transcriptome and adipokine dysregulation leads to fibrosis in visceral adipose depots during diet-induced obesity. BMC Genomics 13:450
26. Huber J, Kiefer FW, Zeyda M et al (2008) CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab 93:3215-3221
27. Rasouli N, Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93(Suppl 1):S64-S73
28. Lumeng CN (2013) Innate immune activation in obesity. Mol Aspects Med 34:12-29
29. Ehses JA, Ellingsgaard H, Boni-Schnetzler M, Donath MY (2009) Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction. Arch Physiol Biochem 115:240-247
30. Ehses JA, Perren A, Eppler E et al (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356-2370
31. Lan H, Rabaglia ME, Stoehr JP et al (2003) Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility. Diabetes 52:688-700
32. Homo-Delarche F, Calderari S, Irminger JC et al (2006) Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat. Diabetes 55:1625-1633
33. Li X, Zhang L, Meshinchi S et al (2006) Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes 55:2965-2973
34. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD (2000) The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci U S A 97:11371-11376
35. van de Woestijne AP, Monajemi H, Kalkhoven E, Visseren FL (2011) Adipose tissue dysfunction and hypertriglyceridemia: mechanisms and management. Obes Rev 12:829-840
36. Guilherme A, Virbasius JV, Puri V, Czech MP (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367-377
37. Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9:311-326
38. Perez-Perez R, Garcia-Santos E, Ortega-Delgado FJ et al (2012) Attenuated metabolism is a hallmark of obesity as revealed by comparative proteomic analysis of human omental adipose tissue. J Proteome 75:783-795
39. Kalaany NY, Mangelsdorf DJ (2006) LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol 68:159-191
40. Venteclef N, Jakobsson T, Steffensen KR, Treuter E (2011) Metabolic nuclear receptor signaling and the inflammatory acute phase response. Trends Endocrinol Metab 22:333-343
41. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9:213-219
42. Brunham LR, Kruit JK, Verchere CB, Hayden MR (2008) Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest 118:403-408